Cogent Biosciences, Inc.
COGT
$37.93
$0.621.66%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -32.77% | -31.47% | -28.56% | -21.49% | -25.12% |
| Total Depreciation and Amortization | 6.93% | 4.00% | 5.33% | 12.71% | 18.58% |
| Total Amortization of Deferred Charges | 1,646.03% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 110.78% | 75.15% | 59.70% | 25.56% | -12.34% |
| Change in Net Operating Assets | -103.89% | -41.72% | -30.92% | -61.81% | 37.77% |
| Cash from Operations | -31.65% | -28.43% | -27.26% | -28.56% | -31.78% |
| Capital Expenditure | -64.09% | -38.67% | -171.20% | -0.62% | -57.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -347.69% | -568.05% | -1,124.41% | -17.99% | 223.44% |
| Cash from Investing | -349.81% | -574.02% | -1,143.80% | -16.89% | 222.32% |
| Total Debt Issued | 352.62% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,878.86% | 2,011.00% | 232.79% | 13.96% | -88.38% |
| Repurchase of Common Stock | -322.46% | -322.46% | -322.46% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -569.40% | -- | -- | 50.83% | 176.13% |
| Cash from Financing | 1,082.65% | 3,471.20% | 309.53% | 35.05% | -66.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.10% | 228.76% | 376.82% | 179.32% | 131.23% |